<SEC-DOCUMENT>0001104659-23-091325-index.html : 20230814 <SEC-HEADER>0001104659-23-091325.hdr.sgml : 20230814 <ACCEPTANCE-DATETIME>20230814160917 ACCESSION NUMBER: 0001104659-23-091325 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 EFFECTIVENESS DATE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 231170072 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>NT 10-Q <SEQUENCE>1 <FILENAME>tm2323616d1_nt10q.htm <DESCRIPTION>NT 10-Q <TEXT> Document 1 - file: tm2323616d1_nt10q.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tm2323616d1_nt10qimg001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tm2323616d1_nt10qimg001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm2323616d1_nt10qimg002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm2323616d1_nt10qimg002.jpg
</DOCUMENT> </SEC-DOCUMENT>